KANGO SUJAY (SVP, Chief Commercial Officer) sold 21.3% of their position (5K shares) of ACCELERON PHARMA INC on the open market
Open‑market sale worth $875.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/27/2021ACC: 0001179110-21-008949
Officer· SVP, Chief Commercial Officer
Since Jan 2019
-5K
Net shares
Net seller
$875.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$40.61
Trade value
$203.05K
% of position
27.0%
9/27/2021
18.51K→23.51K
Common Stock
Direct
Shares
−5K
Price / share
$175.00
Trade value
$875K
% of position
21.3%
9/27/2021
23.51K→18.51K
Total
Net shares
+0.00
Net value
-$671.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/27/2021 | M · Option Exercise | +5K | $40.61 | $203.05K | 27.0% | 18.51K | 23.51K |
| Common Stock Direct | 9/27/2021 | S · Sale | −5K | $175.00 | $875K | 21.3% | 23.51K | 18.51K |
| Total | +0.00 | -$671.95K | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
40.61
Held after
25K
Exercisable
—
9/27/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock5K shares | 9/27/2021 | M · Option Exercise | −5K | 40.61 | — | 25K |